CA2531091A1 - Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique - Google Patents

Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique Download PDF

Info

Publication number
CA2531091A1
CA2531091A1 CA002531091A CA2531091A CA2531091A1 CA 2531091 A1 CA2531091 A1 CA 2531091A1 CA 002531091 A CA002531091 A CA 002531091A CA 2531091 A CA2531091 A CA 2531091A CA 2531091 A1 CA2531091 A1 CA 2531091A1
Authority
CA
Canada
Prior art keywords
genes
expression
ovarian cancer
gene
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002531091A
Other languages
English (en)
Inventor
Christian Nicolas Lavedan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2531091A1 publication Critical patent/CA2531091A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
CA002531091A 2003-07-02 2004-07-01 Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique Abandoned CA2531091A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48446503P 2003-07-02 2003-07-02
US60/484,465 2003-07-02
PCT/EP2004/007167 WO2005005661A2 (fr) 2003-07-02 2004-07-01 Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique

Publications (1)

Publication Number Publication Date
CA2531091A1 true CA2531091A1 (fr) 2005-01-20

Family

ID=34062046

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002531091A Abandoned CA2531091A1 (fr) 2003-07-02 2004-07-01 Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique

Country Status (8)

Country Link
EP (1) EP1644522A2 (fr)
JP (1) JP2007526749A (fr)
CN (1) CN1845999A (fr)
AU (1) AU2004256182A1 (fr)
BR (1) BRPI0412110A (fr)
CA (1) CA2531091A1 (fr)
MX (1) MXPA05014220A (fr)
WO (1) WO2005005661A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10181008B2 (en) 2013-05-30 2019-01-15 Genomic Health, Inc. Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
US10892038B2 (en) 2010-01-11 2021-01-12 Genomic Health, Inc. Method to use gene expression to determine likelihood of clinical outcome of renal cancer

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100068207A1 (en) * 2005-04-07 2010-03-18 Abdallah Fanidi DDR2 in Cancer Diagnosis, Detection and Treatment
EP1806413A1 (fr) * 2006-01-06 2007-07-11 Oligene GmbH Procédé in vitro et outiles pour la détection des differents types de tumeur et prédiction des résultats d'intervention chirurgical du cancer de l'ovaire
CA2669492A1 (fr) * 2006-11-13 2008-05-22 Dermagene Oy Procedes et utilisations impliquant des anomalies genetiques sur le chromosome 12
GB0815846D0 (en) * 2008-09-01 2008-10-08 Immunovia Ab diagnosis, prognosis and imaging of disease
NZ607326A (en) * 2010-08-27 2015-01-30 Universitaetsklinikum Muenster Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr)
CN103920150B (zh) * 2014-04-17 2016-02-03 北京大学第一医院 Satb1在治疗皮肤t细胞淋巴瘤中的应用
JP6436477B2 (ja) * 2014-05-13 2018-12-12 国立大学法人大阪大学 癌治療用医薬組成物
JP6168625B2 (ja) * 2016-01-12 2017-07-26 国立研究開発法人産業技術総合研究所 上皮性卵巣癌鑑別マーカー
CN106841622B (zh) * 2017-04-07 2019-01-18 南通大学附属医院 Scml2在诊断胃肠胰神经内分泌肿瘤中的应用
CN108085392A (zh) * 2018-01-09 2018-05-29 山大生殖研发中心有限公司 上皮性卵巢癌的生物标志物及其用途
CN110241198A (zh) * 2019-05-30 2019-09-17 成都吉诺迈尔生物科技有限公司 一种表征hHRD同源重组缺陷的基因组重组指纹及其鉴定方法
CN112229999B (zh) * 2020-09-01 2022-04-22 浙江省肿瘤医院 一种卵巢癌的预后诊断标志物Claudin21及其应用
CN113684277B (zh) * 2021-09-06 2022-05-17 南方医科大学南方医院 一种基于基因组拷贝数变异的生物标志物预测卵巢癌同源重组缺陷的方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018542A2 (fr) * 1999-09-03 2001-03-15 Millennium Pharmaceuticals, Inc. Compositions, trousses et methodes pour l'identification, l'analyse, la prevention et la therapie du cancer des ovaires
WO2001070979A2 (fr) * 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Nouveaux genes, compositions, trousses et methodes d'identification, de verification, de prevention et de traitement du cancer des ovaires
US20030003479A1 (en) * 2001-04-19 2003-01-02 Millennium Pharmaceutical, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
AU2002324881A1 (en) * 2001-09-05 2003-03-18 Wesleyan University Diagnostic and prognostic tests

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10892038B2 (en) 2010-01-11 2021-01-12 Genomic Health, Inc. Method to use gene expression to determine likelihood of clinical outcome of renal cancer
US11776664B2 (en) 2010-01-11 2023-10-03 Genomic Health, Inc. Method to use gene expression to determine likelihood of clinical outcome of renal cancer
US10181008B2 (en) 2013-05-30 2019-01-15 Genomic Health, Inc. Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
US11551782B2 (en) 2013-05-30 2023-01-10 Genomic Health, Inc. Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer

Also Published As

Publication number Publication date
EP1644522A2 (fr) 2006-04-12
JP2007526749A (ja) 2007-09-20
MXPA05014220A (es) 2006-03-09
AU2004256182A1 (en) 2005-01-20
WO2005005661A3 (fr) 2005-07-14
BRPI0412110A (pt) 2006-11-21
WO2005005661A2 (fr) 2005-01-20
CN1845999A (zh) 2006-10-11

Similar Documents

Publication Publication Date Title
EP1410011B1 (fr) Diagnostic et prevision du cancer du sein chez des patients
US7171311B2 (en) Methods of assigning treatment to breast cancer patients
Diao et al. The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray
JP4606879B2 (ja) Ｅｇｆｒ陽性癌の遺伝子発現プロファイリング
US20070198198A1 (en) Methods and apparatuses for diagnosing AML and MDS
US20040018513A1 (en) Classification and prognosis prediction of acute lymphoblastic leukemia by gene expression profiling
US20090203588A1 (en) Outcome prediction and risk classification in childhood leukemia
US20070154931A1 (en) Genes associate with progression and response in chronic myeloid leukemia and uses thereof
CA2776751A1 (fr) Procedes destines a predire l'issue clinique d'un cancer
JP2014509189A (ja) 結腸ガン遺伝子発現シグネチャーおよび使用方法
JP2006506093A5 (fr)
CA2531091A1 (fr) Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique
US20090118132A1 (en) Classification of Acute Myeloid Leukemia
US20130178391A1 (en) Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers
CA2939539A1 (fr) Survie au cancer de la prostate et recurrence de ce dernier
EP2307570B1 (fr) Signature moléculaire du niveau de tumeur hépatique et son utilisation pour évaluer le pronostic et le régime thérapeutique
AU2004210986A1 (en) Methods for monitoring drug activities in vivo
US20120004127A1 (en) Gene expression markers for colorectal cancer prognosis
US20060281091A1 (en) Genes regulated in ovarian cancer a s prognostic and therapeutic targets
US20040175743A1 (en) Methods for monitoring drug activities in vivo
US20030175761A1 (en) Identification of genes whose expression patterns distinguish benign lymphoid tissue and mantle cell, follicular, and small lymphocytic lymphoma
US20110281750A1 (en) Identifying High Risk Clinically Isolated Syndrome Patients
US20080113345A1 (en) Predicting Response And Outcome Of Metastatic Breast Cancer Anti-Estrogen Therapy
WO2011038763A1 (fr) Procédé de détection biomoléculaire de maladies hépatiques humaines, compositions et trousses utilisés dans ledit procédé
US20070099190A1 (en) Method for distinguishing leukemia subtypes

Legal Events

Date Code Title Description
FZDE Dead